Table 3.
Clinical Outcomes of SARS-CoV-2-Positive Transplant and Waitlist Patients
| Pt | Tx or W/L Pt | Time From Tx or W/L to SARS-CoV-2 (mo) | Hospital Admission | LOS (days) | ICU Admission | Death | Graft Dysfunction | Graft Failure | WCC (×103/μL) | Lymphocyte count (×103/μL) | CRP (mg/L) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Tx | 122 | Yes | 6 | Yes | Yes | 6.5 | 0.2 | 229 | ||
| 2 | Tx | 10 | Yes | 43 | 5.4 | 0.2 | 42 | ||||
| 3 | Tx | 135 | |||||||||
| 4 | Tx | 218 | Yes | 9 | Yes | 9.6 | 0.7 | 97 | |||
| 5 | Tx | 122 | Yes | 6 | Yes | 4.3 | 0.9 | 48 | |||
| 6 | Tx | 64 | Yes | 22 | Yes | Yes | 8.6 | 0.7 | 42 | ||
| 7 | Tx | 356 | Yes | 15 | Yes | Yes | 3.4 | 0.7 | 47 | ||
| 8 | Tx | 243 | Yes | 6 | Yes | Yes | 10.5 | 2.5 | 122 | ||
| 9 | Tx | 204 | Yes | 17 | Yes | Yes | 4.8 | 0.5 | 77 | ||
| 10 | Tx | 317 | Yes | 16 | Yes | Yes | 1.2 | 0.3 | 152 | ||
| 11 | Tx | 9 | Yes | 4 | Yes | 6.2 | 0.1 | 47 | |||
| 12 | Tx | 86 | Yes | 12 | Yes | Yes | Yes | 9.3 | 2.1 | 60 | |
| 13 | Tx | 153 | Yes | 24 | Yes | 6.3 | 0.9 | 16 | |||
| 14 | W/L | 8 | Yes | 16 | Yes | Yes | 9 | 0.7 | 220 | ||
| 15 | W/L | 24 | Yes | 24 | 7.8 | 0.7 | 255 | ||||
| 16 | W/L | 12 | Yes | 27 | 2.7 | 0.7 | 42 | ||||
| 17 | W/L | 33 | Yes | 12 | 2.1 | 0.4 | 135 | ||||
| 18 | W/L | 22 | 7.2 | 1 | 7 | ||||||
| 19 | W/L | 5 | Yes | 5 | 5.6 | 0.9 | 39 | ||||
| 20 | W/L | 69 | 4.7 | 1 | |||||||
| 21 | W/L | 13 |
Abbreviations: CRP, C-reactive protein; ICU, intensive care unit; LOS, length of stay; Pt, patient; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; Tx, transplant; WCC, white cell count; W/L, waitlist.